Premier Clinical Research is categorized under Medical Labs in Spokane, WA and active since 2011.
Premier Clinical Research was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Dalyn M Boehm at the company’s single location by writing to 104 West 5th Avenue # 320w, Spokane, Washington WA 99204 or by phoning (509) 343-3710. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Premier Clinical Research |
| Contact Person: | Dalyn M Boehm |
| Address: | 104 West 5th Avenue # 320w, Spokane, Washington 99204 |
| Phone Number: | (509) 343-3710 |
| Website Address: | premierclinicalresearch.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Premier Clinical Research was started in 2011 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dalyn M Boehm for inquiries that concern Premier Clinical Research by calling the company number (509) 343-3710, as your correspondence is most welcome. Additionally, the physical location of the single location of Premier Clinical Research can be found at the coordinates 47.651604,-117.41364 as well as the street address 104 West 5th Avenue # 320w in Spokane, Washington 99204.
For its online presence, you may visit Premier Clinical Research’s website at premierclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.